A61K 2039/55577
Saponins
Official title: {Saponins; Quil A; QS21; ISCOMS}
A61K2039/55577 (Saponins) appears on 531 US grants and 974 published applications in this corpus.
Search patents in A61K- Granted patents
- 531
- Published applications
- 974
- Assignees
- 397
- Inventors
- 1,835
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 7 | 0 |
| 2001 | 14 | 3 |
| 2002 | 9 | 15 |
| 2003 | 11 | 32 |
| 2004 | 18 | 41 |
| 2005 | 20 | 47 |
| 2006 | 15 | 34 |
| 2007 | 10 | 23 |
| 2008 | 7 | 55 |
| 2009 | 17 | 36 |
| 2010 | 17 | 37 |
| 2011 | 18 | 45 |
| 2012 | 11 | 38 |
| 2013 | 16 | 32 |
| 2014 | 15 | 31 |
| 2015 | 28 | 30 |
| 2016 | 22 | 42 |
| 2017 | 31 | 41 |
| 2018 | 27 | 24 |
| 2019 | 27 | 27 |
| 2020 | 20 | 35 |
| 2021 | 19 | 45 |
| 2022 | 19 | 50 |
| 2023 | 22 | 67 |
| 2024 | 24 | 57 |
| 2025 | 29 | 49 |
| 2026 | 25 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Staphylococcus aureus vaccine compositions15 Sep 2026US 12,734,227 B2New York University
- Coronavirus and influenza compositions and methods for using them25 Aug 2026US 12,714,744 B2
- Triterpene saponin variants, methods of synthesis and use thereof4 Aug 2026US 12,698,304 B2Memorial Sloan Kettering Cancer Center
- Coronavirus vaccine formulations28 Jul 2026US 12,691,171 B2
- Modified gene vaccines against avian coronaviruses and methods of using the same21 Jul 2026US 12,685,766 B2Wisconsin Alumni Research Foundation
- Dengue virus serotype-specific modulation of t cell responses8 Oct 2026US 2026/0306621 A1The United States Government as represented by the Department of Veterans Affairs
- Saponin dmlt adjuvants and related uses1 Oct 2026US 2026/0295037 A1Q-Vant Biosciences, Inc.
- Improved alum-anchored immunogens1 Oct 2026US 2026/0295039 A1Massachusetts Institute of Technology
- Universal vaccine for african swine fever virus (asfv) infections17 Sep 2026US 2026/0273039 A1DEI Biopharma
- Nematode vaccine10 Sep 2026US 2026/0263572 A1AgResearch Limited
Most cited
By later US patents
- Saponin adjuvant520US 5,057,540 ACambridge Biotech Corporation · 1991
- Prevention and treatment of amyloidogenic disease160US 6,743,427 B1Neuralab Limited · 2004
- N-Terminal amyloid-β antibodies116US 6,787,637 B1Neuralab Limited · 2004
- Humanized and chimeric N-terminal amyloid beta-antibodies109US 6,750,324 B1Neuralab Limited · 2004
- Vaccines102US 6,544,518 B1SmithKline Beecham Biologicals s.a. · 2003